Second Affiliated Hospital, School Of Medicine, Zhejiang University
Clinical trials sponsored by Second Affiliated Hospital, School Of Medicine, Zhejiang University, explained in plain language.
-
Scientists reprogram immune cells to fight heart scarring
Disease control OngoingThis early-stage study is testing whether modified immune cells can help people with severe heart failure. Researchers take patients' own immune cells, engineer them to target scar tissue in the heart, and then return them to the body. The main goal is to check if this approach i…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo aims to hold back advanced colon cancer
Disease control OngoingThis study is testing if adding a drug called sintilimab (an immunotherapy) to a standard chemotherapy combination works better for controlling advanced colorectal cancer that has spread. It is for adults with a specific genetic type of cancer (RAS-mutant) who have not yet receiv…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Study tests if your own blood can heal shoulder tears better than steroids
Disease control OngoingThis study aims to find the best treatment for different types of shoulder tendon tears after surgical repair. Researchers are comparing three approaches: a steroid injection, an injection of the patient's own concentrated platelets (platelet-rich plasma), and a placebo injection…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New kidney stone surgery challenges standard treatment
Disease control ENROLLING_BY_INVITATIONThis study compares a newer surgery called VISOR against the standard PCNL procedure for removing medium-sized kidney stones (2-4cm). Researchers want to see which method clears stones better and faster while causing fewer side effects like pain, fever, or injury. About 170 patie…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New combo treatment aims to shrink tumors before lung cancer surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy before surgery helps people with operable non-small cell lung cancer. The goal is to see if this combination treatment can better shrink tumors before removal, lower the chance …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Custom cancer vaccine fights to keep esophageal cancer at bay
Disease control OngoingThis early-stage study is testing a personalized vaccine designed to train the immune system to attack a patient's specific esophageal cancer. It is for people who have already completed standard treatments including surgery, chemotherapy, and immunotherapy, with the goal of prev…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New combo therapy aims to shrink tumors before esophageal cancer surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy before surgery is safe and effective for people with a type of esophageal cancer that can be removed by surgery. The goal is to see if this combination treatment can better shri…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Smart pump aims to make eye surgery safer
Disease control OngoingThis study is testing a new 'adaptive fluidics' system designed to make lens surgery (like cataract removal) safer. The system automatically adjusts fluid pressure inside the eye during the operation to prevent dangerous pressure spikes. Researchers will use special imaging to se…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Precision brain surgery trial aims to improve recovery from devastating strokes
Disease control OngoingThis study is comparing two ways to treat a specific type of serious brain bleed (stroke) in the deep brain. It tests whether a precise, minimally invasive surgery to drain the blood clot, followed by clot-busting medicine, leads to better recovery than standard medication alone.…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New capsule tested to stop liver Cancer's return
Disease control OngoingThis study is testing whether Icaritin soft capsules can help prevent liver cancer from returning after surgery in patients at high risk of recurrence. Twenty patients who have had their liver cancer surgically removed will take the capsules and be monitored with regular scans. R…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Shockwave therapy tested to unclog calcified heart arteries
Disease control OngoingThis study is testing if adding a new shockwave therapy to the standard procedure for opening hardened, calcified heart arteries leads to better long-term results for patients. It will compare two groups: one receiving the standard treatment and one receiving the standard treatme…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Doctors question routine antibiotics after bleeding treatment
Disease control OngoingThis study aims to find out if preventive antibiotics are necessary for cirrhosis patients undergoing a follow-up endoscopic procedure to prevent variceal bleeding from happening again. It involves 226 patients who have a history of this type of bleeding. The research compares ou…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New combo therapy aims to zap eye cancer with fewer side effects
Disease control OngoingThis study is testing if a new drug, orelabrutinib, works better and is safer when combined with either very low-dose radiation or another drug called rituximab for a rare, slow-growing lymphoma around the eye. It involves 39 adults with early-stage disease who haven't had prior …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
AI scans could predict lung Cancer's future, study suggests
Diagnosis OngoingThis study looks back at past PET/CT scans from 500 lung cancer patients to see if artificial intelligence (AI) can spot hidden patterns. The goal is to build computer models that can help doctors better stage the cancer, predict its genetic type, and estimate a patient's surviva…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
Zap your migraine away? electrical device trial seeks pain relief
Symptom relief OngoingThis study is testing whether a small electrical stimulation device placed on the skin can help treat migraine attacks. Researchers are comparing the device to a placebo in 206 adults with migraines to see if it reduces headache pain and symptoms like nausea and light sensitivity…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC